BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 17983063)

  • 1. Do breast columnar cell lesions with atypia need to be excised?
    Datrice N; Narula N; Maggard M; Butler J; Hsiang D; Baick C; Lane K
    Am Surg; 2007 Oct; 73(10):984-6. PubMed ID: 17983063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lobular neoplasia in breast core needle biopsy specimens is associated with a low risk of ductal carcinoma in situ or invasive carcinoma on subsequent excision.
    Renshaw AA; Derhagopian RP; Martinez P; Gould EW
    Am J Clin Pathol; 2006 Aug; 126(2):310-3. PubMed ID: 16891208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Breast calcifications with percutaneous vacuum-assisted biopsy diagnosis of malignancy or atypical hyerplasia: correlations with surgical findings].
    Piubello Q; Montemezzi S; D'Atri C
    Pathologica; 2002 Dec; 94(6):299-305. PubMed ID: 12540993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of invasive breast carcinoma among women diagnosed with ductal carcinoma in situ and lobular carcinoma in situ, 1988-2001.
    Li CI; Malone KE; Saltzman BS; Daling JR
    Cancer; 2006 May; 106(10):2104-12. PubMed ID: 16604564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bilateral and multifocal breast carcinoma. A clinical and autopsy study with special emphasis on carcinoma in situ.
    Ringberg A; Palmer B; Linell F; Rychterova V; Ljungberg O
    Eur J Surg Oncol; 1991 Feb; 17(1):20-9. PubMed ID: 1847343
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lobular neoplasia in breast core needle biopsy specimens is not associated with an increased risk of ductal carcinoma in situ or invasive carcinoma.
    Renshaw AA; Cartagena N; Derhagopian RP; Gould EW
    Am J Clin Pathol; 2002 May; 117(5):797-9. PubMed ID: 12090431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidental finding of mammary carcinoma in lumpectomy specimens.
    Tang P; Hajdu SI; Conte CC; Filardi DA
    Ann Clin Lab Sci; 2003; 33(1):23-31. PubMed ID: 12661895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of concurrent proliferative high-risk lesions on the risk of ipsilateral breast carcinoma recurrence and contralateral breast carcinoma development in patients with ductal carcinoma in situ treated with breast-conserving therapy.
    Adepoju LJ; Symmans WF; Babiera GV; Singletary SE; Arun B; Sneige N; Pusztai L; Buchholz TA; Sahin A; Hunt KK; Meric-Bernstam F; Ross MI; Ames FC; Kuerer HM
    Cancer; 2006 Jan; 106(1):42-50. PubMed ID: 16333852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinicopathologic analysis of breast lesions associated with multiple papillomas.
    Ali-Fehmi R; Carolin K; Wallis T; Visscher DW
    Hum Pathol; 2003 Mar; 34(3):234-9. PubMed ID: 12673557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atypical lobular hyperplasia or lobular carcinoma in situ at core-needle breast biopsy.
    Berg WA; Mrose HE; Ioffe OB
    Radiology; 2001 Feb; 218(2):503-9. PubMed ID: 11161169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concurrent lobular neoplasia increases the risk of ipsilateral breast cancer recurrence in patients with ductal carcinoma in situ treated with breast-conserving therapy.
    Rudloff U; Brogi E; Brockway JP; Goldberg JI; Cranor M; Wynveen CA; Nehhozina T; Reiner AS; Patil S; Van Zee KJ
    Cancer; 2009 Mar; 115(6):1203-14. PubMed ID: 19170233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical importance of histologic grading of lobular carcinoma in situ in breast core needle biopsy specimens: current issues and controversies.
    Gao F; Carter G; Tseng G; Chivukula M
    Am J Clin Pathol; 2010 May; 133(5):767-71. PubMed ID: 20395524
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ductal carcinoma in situ in core biopsies containing invasive breast cancer: correlation with extensive intraductal component and lumpectomy margins.
    Dzierzanowski M; Melville KA; Barnes PJ; MacIntosh RF; Caines JS; Porter GA
    J Surg Oncol; 2005 May; 90(2):71-6. PubMed ID: 15844190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lobular neoplasia on core-needle biopsy--clinical significance.
    Arpino G; Allred DC; Mohsin SK; Weiss HL; Conrow D; Elledge RM
    Cancer; 2004 Jul; 101(2):242-50. PubMed ID: 15241819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Papillomas and atypical papillomas in breast core needle biopsy specimens: risk of carcinoma in subsequent excision.
    Renshaw AA; Derhagopian RP; Tizol-Blanco DM; Gould EW
    Am J Clin Pathol; 2004 Aug; 122(2):217-21. PubMed ID: 15323138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidemiological survey of preinvasive breast cancer.
    Vandenbroucke A; Bourdon C
    Eur J Cancer Prev; 1993 Nov; 2 Suppl 3():3-10. PubMed ID: 8298449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathologic findings of follow-up surgical excision for lobular neoplasia on breast core biopsy performed for calcification.
    Zhao C; Desouki MM; Florea A; Mohammed K; Li X; Dabbs D
    Am J Clin Pathol; 2012 Jul; 138(1):72-8. PubMed ID: 22706860
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lobular carcinoma in situ at percutaneous breast biopsy: surgical biopsy findings.
    Liberman L; Sama M; Susnik B; Rosen PP; LaTrenta LR; Morris EA; Abramson AF; Dershaw DD
    AJR Am J Roentgenol; 1999 Aug; 173(2):291-9. PubMed ID: 10430122
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The florid subtype of lobular carcinoma in situ: marker or precursor for invasive lobular carcinoma?
    Bagaria SP; Shamonki J; Kinnaird M; Ray PS; Giuliano AE
    Ann Surg Oncol; 2011 Jul; 18(7):1845-51. PubMed ID: 21287281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extent and histologic pattern of atypical ductal hyperplasia present on core needle biopsy specimens of the breast can predict ductal carcinoma in situ in subsequent excision.
    Wagoner MJ; Laronga C; Acs G
    Am J Clin Pathol; 2009 Jan; 131(1):112-21. PubMed ID: 19095574
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.